Table 4 Prevalence of symptoms.
From: Assessment of physiological signs associated with COVID-19 measured using wearable devices
Symptom | All (%) | Asx. | Mild(%) | Mod(%) | Sev/crit(%) |
|---|---|---|---|---|---|
Male (female) | – | Male (female) | Male (female) | Male (female) | |
Fatigue | 66.1 (76.1) | – | 69.9 (80.5) | 82.9 (92.3) | 76.8 (89.1) |
Headache | 53.7 (71.4) | – | 57.6 (76.0) | 68.2 (86.9) | 57.1 (78.3) |
Body ache | 58.4 (64.4) | – | 59.4 (64.8) | 77.1 (81.4) | 69.6 (81.9) |
Decrease in taste & smell | 50.2 (64.9) | – | 54.3 (69.6) | 62.4 (77.1) | 53.6 (76.1) |
Cough | 55.2 (59.9) | – | 50.0 (59.1) | 78.8 (76.2) | 76.8 (81.9) |
Fever | 59.4 (52.0) | – | 57.6 (48.0) | 78.2 (68.5) | 83.9 (80.4) |
Chills | 51.0 (51.1) | – | 50.4 (47.0) | 68.8 (68.6) | 64.3 (73.9) |
Congestion | 36.9 (53.0) | – | 42.8 (60.8) | 48.2 (61.5) | 19.6 (43.5) |
Loss of appetite | 39.3 (48.0) | – | 36.6 (44.6) | 51.8 (61.8) | 62.5 (79.0) |
Shortness of breath | 37.2 (46.1) | – | 25.4 (38.1) | 57.6 (64.4) | 80.4 (84.1) |
Sore throat | 30.1 (45.7) | – | 30.1 (49.6) | 41.8 (56.3) | 32.1 (39.1) |
Diarrhea | 32.7 (42.0) | – | 30.8 (38.5) | 44.7 (57.3) | 44.6 (58.0) |
Chest pain | 30.2 (41.9) | – | 27.2 (35.4) | 42.9 (59.7) | 44.6 (65.2) |
Neck pain | 14.3 (26.3) | – | 15.2 (23.9) | 18.8 (37.3) | 14.3 (30.4) |
Hoarse voice | 15.0 (23.5) | – | 13.0 (22.0) | 20.0 (32.0) | 28.6 (27.5) |
Stomach ache | 10.1 (22.9) | – | 10.5 (20.1) | 13.5 (33.2) | 10.7 (28.3) |
Eye pain | 13.8 (21.0) | – | 15.2 (19.9) | 15.9 (28.7) | 17.9 (23.2) |
Confusion | 15.2 (18.0) | – | 10.9 (13.5) | 23.5 (25.8) | 30.4 (38.4) |
Vomiting | 5.2 (10.6) | – | 4.3 (7.2) | 6.5 (14.6) | 12.5 (29.0) |
Rash | 4.7 (8.3) | – | 5.8 (6.7) | 5.9 (11.6) | 1.8 (15.9) |
Swelling in the fingers & toes | 2.1 (6.4) | – | 1.8 (4.2) | 2.4 (9.5) | 5.4 (14.5) |
